AlphAIalphai — Financial news for AI agents
yahoo.comAUG 252 min read$BXP

Is Wall Street Bullish or Bearish on BXP Stock?

Analysts covering BXP stock have a consensus 'Moderate Buy' rating, with 11 'Strong Buy' and 12 'Hold' ratings. This is more bullish than three months ago. Deutsche Bank maintained a 'Hold' rating with a $70 price target. The mean target is $74.26, a 9.7% premium to current levels, with a high target of $90.

Original reporting
yahoo.com
Published Aug 25, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 9:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Is Wall Street Bullish or Bearish on BXP Stock? — source image
Source · yahoo.com
Decision brief

The 30-second read

$BXPBullishMed
01

Why it matters

The upward revision signals renewed confidence in Boston Properties' earnings outlook.

02

Market read

New target levels may prompt reallocation into BXP by income-focused investors.

03

What to watch

Potential slowdown in leasing activity and rising vacancy rates could limit upside.

Relevance 6/10Novelty 6/10Timing: as of Aug 25 2026

Background

Analyst consensus and price targets are a common gauge of market expectations for REITs.

Company-level read

Ticker impact

$BXPBullishMedium confidence
Context

Analysts raised consensus to Moderate Buy with a mean price target of $74.26 and a high target of $90, indicating potential upside.

Expected impact

Potential short-term rally as investors adjust expectations.

Evidence & confidence

Fresh target revisions are primary information and can drive buying interest.

Market effects

Sector

May lift sentiment for office REIT sector if targets are seen as credible.

Regional

Limited to US office REITs and related real estate funds.

Global

Low global impact, primarily US investors.

Counterpoint

What could challenge this read

If the office market remains weak, the targets could be overly optimistic.

Key entities

  • Analyst
    Deutsche Bank

    Maintained Hold rating with $70 target.

Read at source← All news

Related articles

AUG 26
$BXPMedAI 8/10

Did BXP’s (BXP) Upbeat Q2 Beat and Higher FFO Outlook Just Shift Its Investment Narrative?

BXP reported Q2 2026 earnings exceeding expectations and raised its full-year FFO outlook, citing improved business fundamentals. The company's investment narrative hinges on high-quality office and life science space in key markets, with risks tied to new developments and leasing. BXP's $1.2B construction loan for 343 Madison Avenue highlights both potential and risks. Analysts' earnings estimates for 2029 range from $290.1M to $343.6M, with revenue projections between $3.7B and $3.8B.

sahmcapital.com2 min
AUG 19
$BXPMedAI 8/10

BXP's $1.2 Billion 343 Madison Loan Advances a Major Growth Project

BXP closed a $1.2B loan for its $2B 343 Madison Ave project, reducing equity needs to $341M. The 4-year loan at Term SOFR + 2.50% (declining to +2.25% upon milestones) funds 60% of costs. BXP targets 7.5%-8% returns, pending leasing and construction progress. The project is 50% pre-leased, with delivery expected in late 2029.

tradingview.com2 min
JUL 30
$BXPMed

BXP, Inc. Q2 2026 Earnings Call Summary

Strategic Performance and Market Dynamics BXP delivered a strong second quarter, exceeding FFO guidance by $0.08 and raising the 2026 midpoint by $0.05, driven by faster-than-expected leasing and occupancy gains. Management attributes the leasing momentum to a 'very healthy environment' for premier workplaces, noting that AI is acting as a significant tailwind by driving space expansions and upgrades among tech and professional service firms.

yahoo.com7 min
JUL 29
$BXPMed

BXP Secures $1.2B Construction Loan for 343 Madison Avenue Office Tower – Commercial Observer

BXP announced it secured a $1.2B construction loan for its 930,000 sq ft, 46-story office tower at 343 Madison Ave in Midtown, with a four-year term plus a one-year extension option, from Wells Fargo, Bank of America Securities, BNY Mellon and J.P. Morgan. Completion is set for 2029; the project is 50% pre-leased. BXP reported Q2 2026 FFO of $283.4M ($1.78/share) and revenue of $895.7M.

commercialobserver.com6 min
JUL 20
$BXPMed

BXP Selling 7 Times Square Ground Lease

Boston Properties (BXP) is marketing the 7 Times Square ground lease via Eastdil Secured, hiring Will Silverman and Gary Phillips. BXP expects proceeds of $700 million to $750 million, with bids due soon. The 1.2M sq ft tower has a 99-year lease and is 91% occupied. The deal would test Times Square office demand.

commercialobserver.com6 min
JUN 24
$BXPMed

Q3 Financial Results 2025-26

Beximco Pharmaceuticals PLC (AIM: BXP) reported unaudited Q3 and nine-month results ended 31 March 2026. For nine months, net sales rose 13.1% to BDT 41,428.0m (£256.9m) and profit after tax increased 34.0% to BDT 7,048.6m (£43.7m). In Q3, net sales grew 8.1% to BDT 13,627.8m (£84.5m) and PAT rose 30.6% to BDT 2,254.4m (£14.0m).

investegate.co.uk2 min